CClinicalTrials.gg
Not yet recruitingNCT07805265Updated Sep 4, 2026

Effect of Sensorimotor Training on Pain and Gait Performance in Patients With Discogenic Sciatica

An interventional study of Standard physical therapy and Sensorimotor Training in Sciatica Due to Intervertebral Disc Disorder, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
30 Years to 55 Years
Sex
All
01

Study summary

This study aims to investigate the effect of sensorimotor training on gait performance in patients with discogenic sciatica.

Read the detailed description

Discogenic sciatica is commonly associated with pain, functional limitations, and alterations in gait performance resulting from nerve root involvement and impaired neuromuscular control. Sensorimotor training is an active rehabilitation approach that integrates sensory input with motor responses and may improve proprioception, postural control, balance, and movement coordination.

This study will investigate the additional effect of sensorimotor training in patients with chronic discogenic sciatica. Participants will receive a conventional physical therapy program consisting of interferential current therapy, hot packs, positioning according to directional preference, and static abdominal and back exercises. The experimental intervention will incorporate additional sensorimotor training, including proprioceptive neuromuscular facilitation (PNF)-based trunk exercises, balance training on unstable surfaces, colored-path sensorimotor exercises, and the Star Excursion Balance Exercise.

The sensorimotor program will use progressive task-specific exercises designed to challenge proprioception, balance, trunk control, and neuromuscular coordination. Exercise difficulty will be gradually progressed according to participants' abilities through changes in surface stability, movement complexity, reach distance, walking speed, and the incorporation of dual-task activities.

The study will evaluate changes in spatiotemporal gait parameters, pressure-pain threshold, and functional disability before and after the intervention. The findings may provide evidence regarding whether adding sensorimotor training to conventional physical therapy offers additional benefits for gait performance, pain-related outcomes, and functional ability in patients with chronic discogenic sciatica.

02

Conditions studied

  • Sciatica Due to Intervertebral Disc Disorder
03

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Thirty patients of both sexes diagnosed with lumbar disc herniation affecting the L4-L5 and/or L5-S1 nerve roots will be included in this study.
  • Presence of lumbar disc herniation (LDH) will be confirmed by magnetic resonance imaging (MRI).
  • Age will range from 30 to 55 years.
  • Patients experiencing radiating pain along the sciatic nerve distribution (symptoms persisting for more than 3 months).
  • All patients must be employed in office-based jobs.
  • Berg Balance Scale score will range from 21 to 40 (moderate balance impairment).
  • Body Mass Index (BMI) will be within the normal to overweight range (18.5 29.9 kg/m²).
  • All the patients will be able to walk independently with or without minimal assistance.

Exclusion criteria

Exclusion Criteria:

  • Patients with a history of spinal surgery will be excluded.
  • Presence of central neurological disorders (e.g., stroke).
  • Patients with other causes of low back pain which is not related to discogenic origin.
  • Affections of the musculoskeletal system including fractures.
  • Patients with severe balance impairment (Berg Balance Scale score \< 21).
  • Presence of vestibular disorders or visual impairments affecting balance.
  • Patients are currently participating in other rehabilitation programs.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Standard physical therapy

    Participants in this arm will receive a standard physical therapy program consisting of interferential current therapy, hot packs, positioning according to directional preference, and static abdominal and back exercises. The treatment will be administered three sessions per week for two months, with each session lasting approximately 45-60 minutes.

    Other: Standard physical therapy

  • Experimental
    Sensorimotor Training Plus Standard Physical Therapy

    Participants in this arm will receive the same standard physical therapy program administered to the active comparator arm, in addition to a sensorimotor training program. The sensorimotor training will include PNF-based trunk exercises, balance training on unstable surfaces, colored-path sensorimotor exercises, and the Star Excursion Balance Exercise. The treatment will be administered three sessions per week for two months, with each session lasting approximately 45-60 minutes.

    Other: Standard physical therapy · Other: Sensorimotor Training

Interventions

  • OtherStandard physical therapy

    Standard physical therapy will include interferential current therapy applied over the lumbar region at 80-100 Hz for 15-20 minutes, hot packs applied over the lumbar paraspinal region for 10 minutes, positioning according to the patient's directional preference for 10 minutes or as tolerated, and static abdominal and back exercises targeting the transversus abdominis and multifidus. The exercises will be performed as 3 sets of 10 repetitions, with each contraction held for 10 seconds followed by 5 seconds of rest.

  • OtherSensorimotor Training

    Sensorimotor training will include PNF-based trunk exercises, balance training on unstable surfaces, colored-path sensorimotor exercises, and the Star Excursion Balance Exercise. The program will incorporate progressive challenges to trunk control, balance, proprioception, and neuromuscular coordination. Progression will include unstable surfaces, alternating limb movements, single-leg and cross bridging, increased walking speed, dual-task activities, increased reach distance, and increased exercise complexity according to patient tolerance.

05

What researchers measure

Primary outcomes

  1. Walking Speed

    Walking speed will be assessed using the FreeMed® baropodometric platform with FREESTEP software and reported in meters per second (m/s).

    Time frame: 2 months

  2. Stride Length

    Stride length will be assessed using the FreeMed® baropodometric platform with FREESTEP software and reported in millimeters (mm).

    Time frame: 2 months

  3. Cadence

    Cadence will be assessed using the FreeMed® baropodometric platform with FREESTEP software and reported as steps per minute (steps/min).

    Time frame: 2 months

  4. Stance Time

    Stance time will be assessed using the FreeMed® baropodometric platform with FREESTEP software and reported in seconds (s).

    Time frame: 2 months

Secondary outcomes

  1. Pressure-Pain Threshold

    Pressure-pain threshold will be assessed using a pressure algometer at the lumbar paraspinal, gluteus medius, and piriformis muscles. Higher values indicate greater pressure-pain tolerance.

    Time frame: 2 months

  2. Functional Disability

    Functional disability will be assessed using the Oswestry Disability Index (ODI). The score will be expressed as a percentage from 0% to 100%, with higher scores indicating greater disability.

    Time frame: 2 months

06

Study locations

1 site
  • Outpatient clinic at the Faculty of Physical Therapy, Delta University
    Gamasa, Egypt
07

Registry details

Key details

Study ID
NCT07805265
Lead sponsor
Cairo University
Responsible party
Yara Ahmed Mansour (Principal Investigator, Cairo University) — Principal investigator
First posted
Sep 4, 2026
Start date
Sep 7, 2026 (estimated)
Primary completion
Jan 7, 2027 (estimated)
Completion
Jan 21, 2027 (estimated)
Last update
Sep 4, 2026

Study contacts

Yara Ahmed Mansour, B.Sc
Contact
yara.a.mansour@deltauniv.edu.eg
+20 10 08350127
Hend Mohammad Elsayed Ismail, PhD
Contact
Moshera Hassan Darwiesh, PhD
study chair · Professor, Cairo University
Omar Mohamed Said, PhD
study director · Lecturer, Cairo University
Hend Mohammad Elsayed Ismail, PhD
study director · Lecturer, Delta University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion